| 000 | 01671 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517171806.0 | ||
| 264 | 0 | _c20180116 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a2041-1723 | ||
| 024 | 7 |
_a10.1038/s41467-017-00263-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZervantonakis, Ioannis K | |
| 245 | 0 | 0 |
_aSystems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response. _h[electronic resource] |
| 260 |
_bNature communications _c08 2017 |
||
| 300 |
_a365 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMyeloid Cell Leukemia Sequence 1 Protein _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
| 650 | 0 | 4 | _aSystems Biology |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xmetabolism |
| 650 | 0 | 4 |
_aX-Linked Inhibitor of Apoptosis Protein _xantagonists & inhibitors |
| 700 | 1 | _aIavarone, Claudia | |
| 700 | 1 | _aChen, Hsing-Yu | |
| 700 | 1 | _aSelfors, Laura M | |
| 700 | 1 | _aPalakurthi, Sangeetha | |
| 700 | 1 | _aLiu, Joyce F | |
| 700 | 1 | _aDrapkin, Ronny | |
| 700 | 1 | _aMatulonis, Ursula | |
| 700 | 1 | _aLeverson, Joel D | |
| 700 | 1 | _aSampath, Deepak | |
| 700 | 1 | _aMills, Gordon B | |
| 700 | 1 | _aBrugge, Joan S | |
| 773 | 0 |
_tNature communications _gvol. 8 _gno. 1 _gp. 365 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41467-017-00263-7 _zAvailable from publisher's website |
| 999 |
_c27504848 _d27504848 |
||